BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 10907125)

  • 1. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients.
    Tarnow L; Kjeld T; Knudsen E; Major-Pedersen A; Parving HH
    Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus.
    van Ittersum FJ; de Man AM; Thijssen S; de Knijff P; Slagboom E; Smulders Y; Tarnow L; Donker AJ; Bilo HJ; Stehouwer CD
    Nephrol Dial Transplant; 2000 Jul; 15(7):1000-7. PubMed ID: 10862638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensinogen T235 and ACE insertion/deletion polymorphisms associated with albuminuria in Chinese type 2 diabetic patients.
    Young RP; Chan JC; Critchley JA; Poon E; Nicholls G; Cockram CS
    Diabetes Care; 1998 Mar; 21(3):431-7. PubMed ID: 9540028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control.
    Savage DA; Feeney SA; Fogarty DG; Maxwell AP
    Nephrol Dial Transplant; 1999 Apr; 14(4):891-4. PubMed ID: 10328465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM.
    Doria A; Onuma T; Warram JH; Krolewski AS
    Diabetologia; 1997 Nov; 40(11):1293-9. PubMed ID: 9389421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.
    Jacobsen P; Tarnow L; Carstensen B; Hovind P; Poirier O; Parving HH
    J Am Soc Nephrol; 2003 Nov; 14(11):2843-50. PubMed ID: 14569094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus.
    Miura J; Uchigata Y; Yokoyama H; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1999 Aug; 45(1):41-9. PubMed ID: 10499884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes].
    Buraczyńska M; Ksiazek P; Łopatyński J; Spasiewicz D; Nowicka T; Ksiazek A
    Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Type 2 Diabetic Nephropathy in Asian Populations: An Updated Meta-analysis.
    Ahmad N; Jamal R; Shah SA; Gafor AHA; Murad NAA
    Curr Diabetes Rev; 2019; 15(4):263-276. PubMed ID: 29984662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control.
    Barnas U; Schmidt A; Illievich A; Kiener HP; Rabensteiner D; Kaider A; Prager R; Abrahamian H; Irsigler K; Mayer G
    Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.
    Möllsten A; Kockum I; Svensson M; Rudberg S; Ugarph-Morawski A; Brismar K; Eriksson JW; Dahlquist G
    J Diabetes Complications; 2008; 22(6):377-83. PubMed ID: 18413189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese.
    Thomas GN; Critchley JA; Tomlinson B; Lee ZS; Young RP; Cockran CS; Chan JC
    Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
    J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM.
    Chowdhury TA; Dronsfield MJ; Kumar S; Gough SL; Gibson SP; Khatoon A; MacDonald F; Rowe BR; Dunger DB; Dean JD; Davies SJ; Webber J; Smith PR; Mackin P; Marshall SM; Adu D; Morris PJ; Todd JA; Barnett AH; Boulton AJ; Bain SC
    Diabetologia; 1996 Sep; 39(9):1108-14. PubMed ID: 8877296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension.
    Ringel J; Beige J; Kunz R; Distler A; Sharma AM
    Diabetologia; 1997 Feb; 40(2):193-9. PubMed ID: 9049480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
    Hadjadj S; Belloum R; Bouhanick B; Gallois Y; Guilloteau G; Chatellier G; Alhenc-Gelas F; Marre M
    J Am Soc Nephrol; 2001 Mar; 12(3):541-549. PubMed ID: 11181802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy.
    Osawa N; Koya D; Araki SI; Uzu T; Tsunoda T; Kashiwagi A; Nakamura Y; Maeda S
    J Hum Genet; 2007; 52(2):143-151. PubMed ID: 17143591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population.
    Gutiérrez C; Vendrell J; Pastor R; Llor C; Aguilar C; Broch M; Richart C
    Metabolism; 1997 Aug; 46(8):976-80. PubMed ID: 9258285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.